Regenxbio (RGNX) Interest & Investment Income (2015 - 2025)

Regenxbio's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $2.7 million for Q4 2025.

• In Q4 2025, Interest & Investment Income fell 71.15% year-over-year to $2.7 million; the TTM figure through Dec 2025 stood at $12.2 million (down 34.62% YoY), while the FY2025 annual figure was $12.2 million, down 34.62% from the prior year.
• Interest & Investment Income was $2.7 million for Q4 2025 at Regenxbio, down from $3.6 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $9.5 million in Q4 2024 to a low of $311000.0 in Q4 2021.
• Historically, Interest & Investment Income has averaged $2.7 million across 5 years, with a median of $2.4 million in 2023.
• The sharpest annual moves came in 2021 and 2022: Interest & Investment Income plunged 97.75% in 2021, then jumped 551.45% in 2022.
• A 5-year view of Interest & Investment Income shows it stood at $311000.0 in 2021, then surged by 551.45% to $2.0 million in 2022, then grew by 16.78% to $2.4 million in 2023, then jumped by 302.2% to $9.5 million in 2024, then tumbled by 71.15% to $2.7 million in 2025.
• The last three Interest & Investment Income figures came in at $2.7 million (Q4 2025), $3.6 million (Q3 2025), and $3.4 million (Q2 2025), per Business Quant data.